LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
62.06
-1.78 (-2.79%)
At close: Mar 9, 2026, 4:00 PM EDT
62.06
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:20 PM EDT
LivaNova Employees
LivaNova had 3,300 employees as of December 31, 2025. The number of employees increased by 400 or 13.79% compared to the previous year.
Employees
3,300
Change (1Y)
400
Growth (1Y)
13.79%
Revenue / Employee
$420,622
Profits / Employee
-$73,476
Market Cap
3.39B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3,300 | 400 | 13.79% |
| Dec 31, 2024 | 2,900 | 0 | - |
| Dec 31, 2023 | 2,900 | 0 | - |
| Dec 31, 2022 | 2,900 | -100 | -3.33% |
| Dec 31, 2021 | 3,000 | -1,000 | -25.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bruker | 11,396 |
| Integer Holdings | 11,000 |
| Bio-Rad Laboratories | 7,450 |
| Haemonetics | 3,023 |
| iRhythm Holdings | 2,400 |
| Artivion | 1,800 |
| Inspire Medical Systems | 1,333 |
| Glaukos | 1,094 |
LIVN News
- 7 days ago - Artisan International Small-Mid Fund Q4 2025 Performance Review - Seeking Alpha
- 11 days ago - LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance - Business Wire
- 6 weeks ago - LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - Business Wire
- 7 weeks ago - LivaNova PLC (LIVN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - LivaNova to Present at J.P. Morgan Healthcare Conference in January - Business Wire
- 3 months ago - LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting - Business Wire
- 3 months ago - LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea - Business Wire